Truist Financial reaffirmed their buy rating on shares of Amneal Pharmaceuticals (NYSE:AMRX – Free Report) in a report released on Wednesday, Benzinga reports. The firm currently has a $6.00 target price on the stock. Other equities analysts also recently issued research reports about the company. Barclays increased their price target on Amneal Pharmaceuticals from $4.00 […]
Amneal Pharmaceuticals (NYSE:AMRX) Updates FY 2023 Earnings Guidance theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Amneal Pharmaceuticals (NYSE:AMRX – Get Free Report) had its price objective raised by stock analysts at Barclays from $4.00 to $5.00 in a research report issued on Friday, FlyOnTheWall reports. Barclays‘s price objective indicates a potential upside of 21.65% from the stock’s current price. A number of other brokerages have also weighed in on AMRX. […]
Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Free Report) was up 5.9% during trading on Friday . The stock traded as high as $3.05 and last traded at $3.04. Approximately 499,266 shares traded hands during trading, a decline of 52% from the average daily volume of 1,032,962 shares. The stock had previously closed at $2.87. Wall Street […]
Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Rating)’s share price was up 6.6% on Tuesday . The company traded as high as $2.42 and last traded at $2.42. Approximately 654,116 shares changed hands during mid-day trading, a decline of 33% from the average daily volume of 982,323 shares. The stock had previously closed at $2.27. Wall […]